ArticleBioactive materials2026
Muscle-fiber-inspired nanofibrillar microbundles induce myogenic differentiation in human adipose-derived stem cells.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skeletal muscle function relies on uniaxially organized myofibers, whose aligned extracellular matrix provides instructive topographical cues that regulate myogenic behavior. Here, we introduce a melt electrofibrillation strategy, melt electrowriting (MEW) of poly (ε-caprolactone)/poly (vinyl acetate) blends, followed by selective polyvinyl acetate removal, to fabricate highly aligned nanofibrillar microbundle scaffolds that present collagen-like nanotopography. We first verified biocompatibility and alignment guidance using primary human skeletal muscle cells compared with 2D tissue culture polystyrene controls. We then assessed the myogenic response of human adipose-derived stem cells (hASCs) on nanofibrillar scaffolds relative to conventional MEW-printed microfibers and 2D controls. Nanofibrils supported sustained viability over 35 days and promoted pronounced cell alignment, aligned collagen type-I deposition, and enhanced myogenic differentiation. hASCs on the scaffolds formed myosin-positive, multinucleated myotube-like structures by days 28-35 and exhibited increased MYOG and MYF6 expression by qPCR. Bulk RNA sequencing (day 21) further showed that nanofibrils induce a distinct transcriptional state enriched for muscle development/differentiation and contraction-associated programs, accompanied by activation of mechanosensitive signaling and adhesion-cytoskeleton remodeling pathways (PI3K-Akt, MAPK, Wnt, Hippo, and TGF-β). Titin immunostaining revealed early sarcomere assembly, indicating progression toward maturation. Collectively, nanofibrillar scaffolds establish a programmable, muscle-mimetic fibrillar niche that strengthens topography-driven myogenesis of hASCs and supports prolonged culture, providing a versatile platform for in vitro muscle tissue engineering.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.